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ABSTRACT
Life on earth is rhythmic by essence due to day/night alterna-
tion, and many biological processes are also cyclic. The kidney
has a special role in the organism, controlling electrolytes and
water balance, blood pressure, elimination of metabolic waste
and xenobiotics and the production of several hormones. The
kidney is submitted to changes throughout 24 h with periods
of intense activity followed by calmer periods. Filtration, re-
absorption and secretion are the three components determin-
ing renal function. Here, we review circadian changes related
to glomerular function and proteinuria and emphasize the
role of the clock in these processes.
Keywords: circadian clock, glomerular ﬁltration, kidney,
proteinuria
INTRODUCTION
Alternation of day and night imposes rhythms on all forms
of life, and hence, a metabolic challenge for all organisms
with periods of intense activity and feeding, and periods of
rest and fasting. Task repetition over 24 h allows anticipation
of speciﬁc events such as food intake and its associated
burden on downstream metabolism. But anticipation is made
possible only by the presence of an intrinsic timer and a
system that will prepare the organism for speciﬁc tasks at a
determined time point. Circadian clocks have been described
in almost all organisms from unicellular archeobacteriae to
humans. Molecular aspects of the circadian clock were iden-
tiﬁed several years ago and encompass several transcription
factors (BMAL1, CLOCK, NPAS2) regulating transcription
of their own repressors (PERs and CRYs). This autoregula-
tory feedback loop takes about 24 h to complete and further
regulates up to 10–20% of the transcriptome (see [1] for
review).
During evolution, the kidney was forced to adapt to highly
challenging conditions. If initially the kidney was considered
as an almost purely waste excretory organ, terrestrial adapta-
tion pushed to develop waste recycling, tubular reabsorption
of solutes and urine concentration ability [2]. Thus, the move
away from the initial ocean rendered the kidney more depend-
ent on day/night cycles and anchored renal function in circa-
dian variations.
Renal function is a result of ﬁltration, reabsorption and se-
cretion. All of these functions have been shown to cycle over
24 h, but debates about the underlying regulatory process
remain. The discovery of the molecular clock allowed better
characterization of some of these processes and shed new light
and thoughts on how circadian rhythms may be induced.
Glomerulus and tubules express all components of the
molecular clock. Molecular clocks have been described even in
the invertebrate ﬂy Drosophila which has no glomerulus, but
instead has a high-capacity transporting epithelia in their
kidney equivalent, called Malpighian tubules [3]. The real
roles of these clocks in the kidney, especially in tubular func-
tions, have just started to be unveiled and have recently been
reviewed [4]. In the present review, we focus on the roles of the
clocks in renal ﬁltration and illustrate the possible causative
factors inﬂuencing them. We ﬁrst review evidence of the circa-
dianicity of the glomerular ﬁltration rate (GFR), try to identify
the causes of this rhythmicity by analysing the putative cycli-
city of the major known factors inﬂuencing GFR and search
for evidence of a relationship between disturbance of circadian
GFR and pathologies, including renal insufﬁciency and
© The Author 2014. Published by Oxford University Press on
behalf of ERA-EDTA. All rights reserved.
1475
proteinuria. Of note, particular caution should be exerted re-
garding the human studies presented here as most of them
have been conducted on small populations from various
ethnic origins and may not be applicable in general.
Is GFR circadian?
Time-dependent change in GFR has been described in
different species and its amplitude depends on environmen-
tal conditions. The most extreme example is probably found
in hummingbirds. These birds face dramatic changes
between day, during which they ingest an important amount
of water, and night, where they are exposed to water restric-
tion. Hummingbirds solved this quandary by regulating
their water balance through varying GFR, decreasing GFR in
case of water restriction and even shutting down GFR com-
pletely at night [5]. This regulatory pattern might be
mediated by ADH, regulating directly pre-glomerular arter-
iolae [6, 7].
Several authors have addressed the question of whether
GFR is cyclic in humans. A state-of-the art physiological study
was performed by Koopman et al. [8], who studied 11 normal
volunteers under standardized conditions (identical small
meal every 3 h, bed rest) and measured GFR by inulin clear-
ance and effective renal plasma ﬂow (RPF) by p-aminohippu-
rate clearance. The amplitude of GFR variation was 36 mL/
min over 24 h, representing a 33% variation over the mean.
The peak GFR was reached between 4 and 5 p.m. and the
lowest point was between 2 and 3 a.m. When RPF was mea-
sured, these authors found similar variations with a 214 mL/
min amplitude (34% over the mean) and a peak slightly
shifted to 7–8 p.m. and a nadir at 6–7 a.m. compared with
those of GFR. Due to the shift between GFR and RPF, the ﬁl-
tration fraction (FF = GFR/RPF) also presented an oscillatory
rhythm with a peak at 11 a.m. and a nadir between 1 and
2 a.m. Compared with inulin clearance, endogenous creatinine
clearance showed smaller amplitude, if any, and shifted peak
and nadir. Of note, plasma creatinine levels showed only small
circadian variations (±8 μmol/L or 9.4% over the 24 h mean).
Blocking of tubular creatinine secretion by cimetidine induced
a perfect ﬁt of endogenous creatinine and inulin clearances,
showing the importance of nocturnal secretion of creatinine in
humans [9]. If this variation of GFR over 24 h seems to be
robust in young individuals, it might be blunted in older pa-
tients [10] or at least under particular conditions. Indeed,
when compared with young hypertensive, older hypertensive
subjects had blunted GFR oscillations as measured by creatin-
ine clearance [11].
Noteworthy, at least one study did not ﬁnd any cyclicity of
GFR as measured by both endogenous creatinine and cystatine
C [12]. Further studies comparing 24 h changes in cystatin C
levels and inulin clearance are certainly awaited in order to
conclude.
Altogether, the data published so far show that GFR dis-
plays robust circadian changes in humans. Creatinine clear-
ance might not be a reliable marker of GFR rhythmicity, due
to its strong dependence on proximal tubule secretion, itself
highly upregulated at night.
Factors potentially involved in circadian variations of
GFR
GFR depends on alterations in the ultraﬁltration coefﬁcient
(Kf ) and on the transcapillary hydrostatic pressure difference
(difference between capillary and Bowman’s space hydrostatic
pressure or Δhydrostatic pressure) and on the transcapillary
oncotic pressure difference (difference between capillary and
Bowman’s space oncotic pressure or Δoncotic pressure) as
follows [13]:
GFR ¼ Kf ðDhydrostatic pressure Doncotic pressureÞ
Of all the determinants of GFR, the glomerular capillary
hydrostatic pressure is probably exposed to the most intense
daily ﬂuctuations. Indeed, pressure in the glomerular capillar-
ies is itself inﬂuenced by many factors of which systemic blood
pressure, renal blood ﬂow and changes in afferent or efferent
arteriolar resistance are the most prominent. Arteriolar resist-
ance is partially under intrinsic myogenic control, but can also
be inﬂuenced by other factors including angiotensin II, norepin-
ephrine, renal prostaglandins, atrial natriuretic peptide (ANP),
vasopressin and tubuloglomerular feedback (Table 1). There-
fore, if any one of these factors is affected by circadian variation,
rhythmicity of GFR can be expected. Alternatively, direct
control of GFR by the molecular clock—acting on the myogenic
tonus of efferent arteriolae for instance—could be envisioned,
but was so far not demonstrated.
If direct measurement of capillary hydrostatic pressure over
24 h was never performed, some of the factors inﬂuencing it
are known to change over the day and are reviewed hereafter.
Systemic blood pressure displays well-established circadian
rhythm with clear dipping during the inactivity phase. But its
direct involvement in changing capillary hydrostatic pressure
over 24 h is probably low: Voogel et al. [16] have demonstrated
that circadian changes of GFR are probably independent of
systemic blood pressure.
The sympathetic nervous system may also affect the GFR
differentially between the sleep and awake cycle. It has been
shown in healthy participants, for instance, that sympathetic
nervous activity decreases during sleep [17]. Using microneur-
ography, Somers and colleagues showed that burst frequency
and burst amplitude decreased during phases of the sleep
cycle, except for the rapid eye movement sleep. These varia-
tions in sympathetic nervous activity might directly and/or
Table 1. Factors potentially involved in circadian variations of GFR
Factors inﬂuencing GFR Circadian?
Filtration coefﬁcient Not known
Capillary hydrostatic pressure Not known
Systemic blood pressure Yes [14]
Renal blood ﬂow Yes [8]
Regulation of afferent and efferent arteriolar resistance Yes [15]
Sympathetic system Yes [15]
Hormones (renin, angiotensin II, PGE2, ADH, etc.) Yes [16]
Tubuloglomerular feedback Not known
Bowman’s space hydrostatic pressure Not known
Capillary oncotic pressure Not known
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indirectly affect GFR since progressive stimulation of the renal
sympathetic nervous system leads to stepwise activation of
renin release, renal sodium absorption and decrease of GFR,
as demonstrated in dogs [15]. Using lower body negative pres-
sure as an indirect way of stimulating the sympathetic nervous
system, we were able to conﬁrm these data in humans [18].
However, the effect of this stimulation on the GFR could not
be measured during this experiment. The effect of the sympa-
thetic nervous system on the GFR was studied in seven kidney
transplanted patients considered as denervated with stable
renal function, and compared with 10 healthy volunteers [19].
Normal variations of the GFR, measured by inulin clearance,
were observed in all transplanted patients except for the one
with the lowest function. This suggests a minor role of the
sympathetic nervous system in the regulation of GFR, but
would need further conﬁrmation in other denervated patients.
Several hormones are highly cyclic during 24 h and may in-
ﬂuence GFR through their action on hydrostatic pressure.
Among them, the renin–angiotensin–aldosterone system is of
particular importance, regulating tightly efferent arteriolar
tonus. Sleep/awake cycles have a strong inﬂuence on plasma
renin activity with increase in both frequency and amplitude
of the oscillations in healthy young men [20]. Aldosterone is
related to plasma renin activity during sleep but seems to be
associated to cortisol pulses during awake periods [21]. In 10
healthy volunteers studied under controlled settings (including
position, diet and sleep, but normal light/dark cycles) and
during two periods, at baseline and during a prolonged bed
rest, circadian ﬂuctuations of melatonin, plasma renin activity,
aldosterone and cortisol could be detected [22]. Peak secretion
occurred at night in the following order: melatonin, PRA, al-
dosterone and cortisol. The simultaneous measurement of
hormones of the renin–angiotensin system and melatonin is of
interest since there seems to be an interaction of angiotensin
with melatonin synthesis and release, and both may interfere
with circadian rhythms [23]. Of note, progressive impairment
of renal function is associated with impairment of the en-
dogenous melatonin rhythm [24].
Prostaglandins exert counter-regulation to angiotensin
effect and are of utmost importance for GFR regulation, espe-
cially in aging patients. Intrarenal synthesis of prostaglandins
is dependent on several enzymatic reactions, mainly driven by
the cytochrome P450 family. It has been shown that urine
prostaglandin excretion is circadian with higher levels mea-
sured during the day [25]. We have shown that the metabolism
of prostaglandins, especially of the precursor 20-HETE, was
disturbed in mice in which the molecular clock is disrupted,
affecting sodium balance and blood pressure [26]. Its role on
GFR however has not been studied in detail in this study.
Unlike the hummingbird, there seems to be no circadian
rhythm of vasopressin release in humans. Using copeptin, the
C-terminal vasopressin precursor fragment, Darzy et al. [27]
found no consistent circadian rhythm in seven healthy young
subjects. An earlier study, however, with direct measurement
of vasopressin (AVP), identiﬁed diurnal changes in plasma
AVP with nocturnal increase occurring early during the night
[28]. Consistently, an abnormal diurnal variation of vasopres-
sin has been found in 29 patients with nocturnal polyuria [29].
A more recent study in 15 children with nocturnal polyuria re-
sistant to desmopressin found that the circadian rhythms for
both sodium excretion and for GFR were lost, suggesting that
other factors are involved in the control of the GFR rhythmi-
city [30]. In another study looking at the effect of sleep depriv-
ation on 24-h AVP concentrations, no difference was found
between the baseline period and after sleep deprivation, both
periods showing no signiﬁcant circadian variability of AVP
concentration [31].
Finally, if the above-described factors are mainly determi-
nants of the capillary hydrostatic pressure, oncotic pressure
might also be contributing to circadian changes of GFR. Syn-
thesis and concentration levels of several plasma proteins,
starting with albumin, have a strong circadian rhythm that
may ultimately lead to changes of plasma oncotic pressure,
even if this was never directly measured over 24 h [32].
Circadian GFR and pathologies
Unlike blood pressure where clear epidemiological data of
adverse outcomes associated with higher night-time blood pres-
sure exist [33], similar data regarding GFR could not be re-
trieved in the literature. This might be secondary to the
difﬁculty of obtaining split (day/night) measures of GFR, com-
pared with the relative convenient availability of ambulatory
blood pressure measurement. However, a clear correlation
between night/day alternation in mean arterial blood pressure
and in GFR could be demonstrated in diabetic nephropathy
[34]. Moreover, epidemiological data indicate that alteration of
the blood pressure dipping pattern might be associated with
poorer renal outcome, as assessed by eGFR and proteinuria
[35].
Regarding blood pressure and disruption of circadian
rhythm, Fukuda and colleagues postulated that impaired
daytime sodium excretion could cause a night-time increase of
blood pressure in order to increase pressure natriuresis and
hence keep sodium balance [36–38]. Interestingly, creatinine
clearance has been shown to be associated with decreased
dipping and night-to-day ratio of sodium excretion, suggesting
that patients with impaired renal function need higher night-
time blood pressure to excrete sodium and hence a longer time
to achieve a dipping pattern [14]. The same group subsequently
showed that sodium restriction or the use of diuretics could
restore a dipping pattern of blood pressure in patients with
essential hypertension [36, 39]. In a sample of 20 patients with
chronic kidney disease, the angiotensin II receptor blocker ol-
mesartan could also restore a dipping pattern of BP [40]. This
ﬁnding was attributed to enhanced sodium excretion during
daytime. However, other mechanisms secondary to changes of
renal haemodynamics such as reduced ﬁltration fraction,
which are well-described effects of blockers of the renin–angio-
tensin system, may be implicated [41, 42]. Chronotherapy has
been proposed for restoring the dipping pattern of blood pres-
sure. In hypertensive patients on three antihypertensive drugs,
patients who were randomized to take one of the drugs in the
evening compared with all drugs in the morning had decreased
night-time blood pressure [43]. The proportion of dippers was
signiﬁcantly increased in this group. In patients with CKD, the
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reduced risk of cardiovascular events [44]. These promising
results await further conﬁrmation by double-blind controlled
trial. These studies have focused on blood pressure circadian
changing pattern restoration, but they have not looked at
whether renal function was restored, and if so, how this was
achieved precisely.
The effect of sleep deprivation on renal function was
studied in 10 male and 10 female healthy volunteers [31]. En-
dogenous creatinine clearance was increased, as well as diur-
esis and natriuresis. Moreover, night-time blood pressure was
higher and nocturnal dipping was blunted with more pro-
nounced effects on men than on women. Hormones of the
renin–angiotensin system (renin, angiotensin II and aldoster-
one) were signiﬁcantly lower during sleep deprivation, while
ANP and vasopressin concentrations were not affected.
Patients with stage 5 renal insufﬁciency and on dialysis
seem to have preserved circadian rhythms of plasma phos-
phate, calcium and PTH [45, 46]. But if the rhythms of these
solutes and hormone were not affected in these patients, other
hormones, especially those regulating energy homeostasis,
showed strong alteration of their circadian proﬁle. Suneja and
colleagues showed in 10 fasting dialysed patients, compared
with 8 healthy volunteers, that leptin, PYY and NPY concen-
trations were markedly elevated, while ghrelin concentrations
were lower. Moreover, the 72-h hormonal proﬁles of these
hormones were markedly modiﬁed. This pattern of metabolic
hormones (high leptin, low ghrelin) was suggested to be anor-
exigenic, but this was not documented in these patients.
However, this pattern could be associated with the elevated
blood pressure and with the strikingly increased cardiovascu-
lar mortality seen in these patients [47].
Is proteinuria circadian?
Filtration through glomerulus is a complex process [48].
Filtrate has to cross three different layers before reaching
early proximal tubules: fenestred capillaries, glomerular basal
membranes and slit diaphragm between the podocyte feet. If
any of these structures fails, proteinuria generally develops as
one of the earliest signs and can lead to life-threatening
nephrotic syndrome. However, tubules have strong capacities
in reabsorbing proteins and display efﬁcient protein-reab-
sorbing mechanisms, such as the megalin/cubilin protein re-
absorption system. Proteinuria is thus the result of an
imbalance between excessive ﬁltration of proteins across
glomerulus and/or tubular inability to reabsorb the amount
of protein ﬁltered. As ﬁltration across glomerulus follows cir-
cadian rhythm and most of tubular functions are oscillating
as well, several groups address the possibility of proteinuria
being circadian.
Buzio et al. [49] found that physiologic protein excretion is
circadian and presents a peak which is synchronized with the
maximal GFR and the plasma protein peak concentration.
Similarly, others identiﬁed a peak in urinary protein excretion
in the late afternoon [50]. Glycosaminoglycans, which are part
of the glomerular basal membrane, showed a circadian urinary
excretion rate correlated to GFR in rats [51]. Other tubular
proteins, such as NAG, beta-2 microglobulin, have been
described with circadian rhythms of their excretion rate
closely correlated with urine albumin excretion and GFR [52].
Overt proteinuria seems to display also signiﬁcant circa-
dian rhythmicity. Out of 17 patients with different types of
glomerulopathies and proteinuria, Koopman et al. [53]
found 13 who displayed circadian proteinuria, with a peak at
4 p.m. and a nadir at 3 a.m., independent of the type of
underlying pathology. In further exploration of proteinuria
rhythms, the same Dutch group infused inulin and different
sizes of dextran to eight nephrotic syndrome patients with
preserved renal function and in six normal volunteers. They
found that the nephrotic patients presented circadian pro-
teinuria for dextran size bigger than 45 A, in the phase with
the rhythm of the GFR [54]. Interestingly, nephrotic patients
with inverted sodium rhythms (excreting more sodium at
night than in the day, representing about half of the patients)
had worse proteinuria and worse prognosis of their under-
lying disease, as assessed on biopsies [55]. Based on these
ﬁndings, it was proposed that proteinuria cyclicity could be
attributed to both haemodynamic factors and changes in the
Sieving index [56].
Role of the molecular clock in GFR and proteinuria
The molecular clock is well established as a strong regulator
of expression of RNA, protein, but also as regulator of post-
translational modiﬁcations. However, data showing a direct
implication of the molecular clock in regulation of GFR have
not been published so far. Likewise, a role of the molecular
clock in controlling tubular reabsorption of proteins, including
albumin, is lacking. Conversely, a slight impairment of the
diurnal rhythm of some molecular clock components was re-
cently found in a rodent model of renal insufﬁciency estab-
lished by 5/6 nephrectomy [57].
Regarding the effect of the molecular clock on the different
factors affecting GFR and discussed previously, one of the ﬁrst
questions coming to mind is whether renin production is dir-
ectly regulated by the molecular clock and thus whether the
deletion of the cyclicity of renin may have a direct inﬂuence on
GFR. This will need to be carefully examined in renin speciﬁc-
ally driven Cre-expressing mice crossed with BMAL1 ﬂoxed
mice.
Likewise, putative rhythmicity at the RNA, protein or func-
tional level of the GBM or slit diaphragm components still
needs to be described as well as possible circadian variations of
the protein uptake mechanisms taking place in the proximal
tubule via the megalin/cubilin system for instance.
In conclusion, circadian variation of the GFR is well estab-
lished (up to 30% over the 24 h mean) and complex. Numerous
factors inﬂuencing GFR have been shown to display circadian
rhythm, but it seems from the data gathered so far in the lit-
erature that none of them can by themselves account for the
observed cyclicity. Similarly, ﬁltration and reabsorption of pro-
teins exhibit circadian rhythm but the underlying mechanism
is unknown. Despite the description of the different compo-
nents of the molecular clock >10 years ago, no study has ad-
dressed the role of intracellular clocks on GFR and ﬁltration. A
new era of study is now wide open and needs manpower and
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more and more exposed to disrupted rhythms and in which
renal function deterioration is a major threat, better knowledge
of the relationship between rhythms and renal function is
avidly needed.
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ABSTRACT
Autosomal dominant polycystic kidney disease (ADPKD) is a
common genetic disorder characterized by bilateral renal cyst
formation. The disease is caused by mutations in either the
PKD1 or the PKD2 gene. Progress has been made in under-
standing the molecular basis of the disease leading to the
general agreement on ADPKD being a loss-of-function disease.
Identiﬁcation of signalling cascades dysfunctional in the cystic
epithelia has led to several pre-clinical studies of animal models
using a variety of inhibitors to slow disease progression. These
were followed by clinical trials, some of which generated
promising results, although an approved therapy is still lacking.
Here, we summarize and discuss recent work providing evi-
dence that metabolic alterations can be observed in ADPKD.
In particular, we will focus our discussion on the potential role
of glucose metabolism in the pathogenesis of ADPKD. These
recent ﬁndings provide a new perspective for the understand-
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